FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eric Winer

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Craig A Bunnell; Harold J Burstein; Lynn Colicchio; Barbara Fine; Anne H Gross; Erin E Hagemeister; Nancy A Hilton; Michael Jason Kalfin; Anne E Kelly; Sharon Lane; Ann Partridge; Mary Salisbury; Clare Sullivan; Audrea H Szabatura; Saul N Weingart; Eric P Winer; Susan Mann
High performance teamwork training and systems redesign in outpatient oncology.
Kathryn J Ruddy; Eric P Winer; Anita Giobbie-Hurder; Sharon H Giordano; Shari Goldfarb; Sandra Kereakoglow; Ann H Partridge
Quality of life and symptoms in male breast cancer survivors.
Sharon L Bober; Karen M Emmons; Anita Giobbie-Hurder; Eric P Winer; Ann Partridge
Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eric Winer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Craig A Bunnell; Harold J Burstein; Lynn Colicchio; Barbara Fine; Anne H Gross; Erin E Hagemeister; Nancy A Hilton; Michael Jason Kalfin; Anne E Kelly; Sharon Lane; Ann Partridge; Mary Salisbury; Clare Sullivan; Audrea H Szabatura; Saul N Weingart; Eric P Winer; Susan Mann
High performance teamwork training and systems redesign in outpatient oncology.
BMJ quality & safety 2013;22(5):405-13.
2013: Kathryn J Ruddy; Eric P Winer; Anita Giobbie-Hurder; Sharon H Giordano; Shari Goldfarb; Sandra Kereakoglow; Ann H Partridge
Quality of life and symptoms in male breast cancer survivors.
Breast (Edinburgh, Scotland) 2013;22(2):197-9.
2013: Sharon L Bober; Karen M Emmons; Anita Giobbie-Hurder; Eric P Winer; Ann Partridge
Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ.
The journal of sexual medicine 2013;10(2):370-7.
2012: Erica T Warner; Jane C Weeks; Eric P Winer; Yu-Ning Wong; Douglas W Blayney; Stephen B Edge; Melissa E Hughes; Joyce C Niland; Rebecca A Ottesen; Rulla M Tamimi; Richard L Theriault; Ann H Partridge
Time to diagnosis and breast cancer stage by race/ethnicity.
Breast cancer research and treatment 2012;136(3):813-21.
2012: Lawrence N Shulman; Eric P Winer; James N Atkins; Heather P Becker; Donald A Berry; Constance Cirrincione; Gretchen Kimmick; Silvana Martino; Erica Mayer; Hyman Muss; Larry Norton; Ruth O'Regan; Edith A Perez; Charles J Schneider; Clifford Hudis
Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(33):4071-6.
2012: Nancy U Lin; Joyce C Niland; Richard L Theriault; Ann Vanderplas; Douglas W Blayney; Stephen B Edge; Melissa E Hughes; Eric P Winer; Yu-Ning Wong; Jane C Weeks
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.
Cancer 2012;118(22):5463-72.
2012: Erica L Mayer; Eric P Winer; Wendy Y Chen; Sean R Downing; Rebecca Gelman; Keri Hannagan; Steven J Isakoff; Giannoula Klement; Harold J Burstein
Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics.
Breast cancer research and treatment 2012;136(1):169-78.
2012: Ian Krop; Patricia M LoRusso; Michael Lu; Kathy D Miller; Shanu Modi; Gladys Rodriguez; Lukas Amler; Sandhya Girish; Ellie Guardino; Eric P Winer; Denise Yardley; Maoxia Zheng; Hope S Rugo
A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(26):3234-41.
2012: Ann H Partridge; Kathryn J Ruddy; Jamie Kennedy; Eric P Winer
Model program to improve care for a unique cancer population: young women with breast cancer.
Journal of oncology practice / American Society of Clinical Oncology 2012;8(5):e105-10.
2012: Clifford A Hudis; Hy Muss; Larry Norton; Marc L Citron; Eric P Winer
Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(25):3148-9; author reply 3149-50.
2012: Jennifer A Ligibel; Eric P Winer
Aromatase inhibition in obese women: how much is enough?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(24):2940-2.
2012: Elgene Lim; Otto Metzger-Filho; Eric P Winer
The natural history of hormone receptor-positive breast cancer.
Oncology (Williston Park, N.Y.) 2012;26(8):688-94, 696.
2012: Jennifer A Ligibel; A James O'Malley; Eric P Winer; Gregory W Daniel; Maxine Fisher; Nancy L Keating
Patterns of bone density evaluation in a community population treated with aromatase inhibitors.
Breast cancer research and treatment 2012;134(3):1305-13.
2012: Lisa A Carey; Wing-Keung Chiu; Francisco J Esteva; Madlyn Ferraro; Andres Forero-Torres; Katherine A Hoadley; Timothy J Hobday; Anastasia Ivanova; Minetta C Liu; Cynthia X Ma; Paul Kelly Marcom; Erica L Mayer; Charles M Perou; Mothaffar F Rimawi; Hope S Rugo; Anna Maria Storniolo; Philip S Bernard; Emily Burrows; Antonio C Wolff; Eric P Winer
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(21):2615-23.
2012: Harold J Burstein; Gabriel N Hortobagyi; Kathy S Albain; Larry Norton; Edith A Perez; Martine J Piccart-Gebhart; Eric P Winer; Norman Wolmark; Clifford A Hudis
Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(18):2179-82.
2012: Nancy U Lin; David Mendelson; Pamela Munster; Martina Uttenreuther-Fischer; Richard Vinisko; Duncan Wheatley; Sven Wind; Eric P Winer; Lisa A Carey; Susan Cleator; Laurie Frakes; Agustin A Garcia; Stephen Houston; Hilary Jones; Steve Kelly; Tamas Hickish
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab.
Breast cancer research and treatment 2012;133(3):1057-65.
2012: Jane L Meisel; Susan M Domchek; Anita Giobbie-Hurder; Nancy U Lin; Robert H Vonderheide; Eric P Winer; Ann H Partridge
Quality of life in long-term survivors of metastatic breast cancer.
Clinical breast cancer 2012;12(2):119-26.
2012: L C Collins; S E Come; Shari Gelber; S Kereakoglow; J D Marotti; E F Brachtel; K Cole; K Ruddy; L Schapira; Eric P Winer; Ann H Partridge
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer.
Breast cancer research and treatment 2012;131(3):1061-6.
2012: Ann H Partridge; Douglas W Blayney; Stephen B Edge; Melissa E Hughes; Joyce C Niland; Rebecca A Ottesen; Richard L Theriault; Jane C Weeks; Eric P Winer; Yu-Ning Wong; Rulla M Tamimi
The effect of age on delay in diagnosis and stage of breast cancer.
The oncologist 2012;17(6):775-82.
2011: Nancy U Lin; Stephen D Rubin; Klaudia Steplewski; Mario Campone; Wolfgang Eierman; Richard Greil; Bella Kaufman; Stephen R Lane; Denise Zembryki; Eric P Winer
Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases.
Journal of neuro-oncology 2011;105(3):613-20.
2011: Rachel A Freedman; Rebecca Gelman; Gordon Harris; Ian E Krop; Jennifer A Ligibel; Elizabeth Bullitt; Emily Eisenberg; Ann H Partridge; Lixian Sun; Eric P Winer; Nancy U Lin
A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.
Clinical breast cancer 2011;11(6):376-83.
2011: Beverly Moy; Michael T Halpern; Blase N Polite; Steven K Stranne; Eric P Winer; Dana S Wollins; Lisa A Newman
American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(28):3816-24.
2011: Erin M Olson; Ian E Krop; Nancy U Lin; Eric P Winer
The ethical use of mandatory research biopsies.
Nature reviews. Clinical oncology 2011;8(10):620-5.
2011: Phuong K Morrow; Rodolfo Nuñez; Aysegul A Sahin; Eric P Winer; Gerburg M Wulf; Yan Xiong; Dihua Yu; Siyuan Zhang; Daniel J Booser; Jeanna Coviello; Joe Ensor; Peter R Flores; Gabriel N Hortobagyi; David W Kindelberger; Ian Krop; Julia A Moore; Francisco J Esteva
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(23):3126-32.
2011: Mehra Golshan; Judy E Garber; Rebecca Gelman; Nadine Tung; Barbara L Smith; Susan L Troyan; Caprice C Greenberg; Eric P Winer; P Ryan
Does neoadjuvant bevacizumab increase surgical complications in breast surgery?
Annals of surgical oncology 2011;18(3):733-7.
2011: Nancy L Keating; Mary Beth Landrum; John M Brooks; Elizabeth A Chrischilles; Eric P Winer; Kara Wright; Rita Volya
Outcomes following local therapy for early-stage breast cancer in non-trial populations.
Breast cancer research and treatment 2011;125(3):803-13.
2010: Jennifer A Ligibel; Ann Partridge; Anita Giobbie-Hurder; Nancy Campbell; Laura Shockro; Taylor Salinardi; Taylor Salinardri; Eric P Winer
Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer.
Journal of women's health (2002) 2010;19(8):1553-9.
2010: Judy E Garber; Susan Halabi; Sara M Tolaney; Ellen Kaplan; Laura Archer; James N Atkins; Stephen Edge; Charles L Shapiro; Lynn Dressler; Electra D Paskett; Electra M Paskett; Gretchen Kimmick; James Orcutt; Anthony Scalzo; Eric P Winer; Ellis Levine; Nasir Shahab; Nancy Berliner
Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.
Journal of the National Cancer Institute 2010;102(13):942-9.
2010: Elena M Kouri; Yulei He; Eric P Winer; Nancy L Keating
Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women.
Breast cancer research and treatment 2010;121(3):743-51.
2010: Daniel P Silver; Andrea L Richardson; Aron C Eklund; Zhigang C Wang; Zoltan Szallasi; Qiyuan Li; Nicolai Juul; Chee-Onn Leong; Diana Calogrias; Ayodele Buraimoh; Aquila Fatima; Rebecca S Gelman; Paula D Ryan; Nadine Tung; Arcangela De Nicolo; Shridar Ganesan; alexander miron; Christian Colin; Dennis C Sgroi; Leif W Ellisen; Eric P Winer; Judy E Garber
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(7):1145-53.
2009: Ann H Partridge; Eric P Winer
On mammography--more agreement than disagreement.
The New England journal of medicine 2009;361(26):2499-501.
2009: Nicholas J Petrelli; Eric P Winer; Julie R Brahmer; Sarita Dubey; Sonali Smith; Charles Thomas; Linda Vahdat; Jennifer Obel; Nicholas Vogelzang; Maurie Markman; John W Sweetenham; David G Pfister; Mark G Kris; Lynn Schuchter; Raymond Sawaya; Derek Raghavan; Patricia Anne Ganz; Barnett Kramer
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(35):6052-69.
2009: Jennifer A Ligibel; Anita Giobbie-Hurder; Deanna Olenczuk; Nancy Campbell; Taylor Salinardi; Eric P Winer; Christos S Mantzoros
Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors.
Cancer causes & control : CCC 2009;20(8):1523-8.
2009: Erica L Mayer; Ann H Partridge; Lyndsay N Harris; Rebecca Gelman; S T Schumer; Harold J Burstein; Eric P Winer
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.
Breast cancer research and treatment 2009;117(3):615-23.
2009: Nancy L Keating; Elena Kouri; Yulei He; Jane C Weeks; Eric P Winer
Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
Medical care 2009;47(7):765-73.
2009: Hyman Muss; Donald A Berry; Constance Cirrincione; Maria Theodoulou-Haber; Ann M Mauer; Alice B Kornblith; Ann H Partridge; Lynn Dressler; Harvey J Cohen; Heather P Becker; Patricia A Kartcheske; Judith D Wheeler; Edith A Perez; Antonio C Wolff; Julie R Gralow; Harold J Burstein; Ahmad A Mahmood; Gustav Magrinat; Gutav Magrinat; Barbara A Parker; Ronald D Hart; Debjani Grenier; Larry Norton; Clifford Hudis; Eric P Winer
Adjuvant chemotherapy in older women with early-stage breast cancer.
The New England journal of medicine 2009;360(20):2055-65.
2009: Maria Theodoulou-Haber; Gerald Batist; Susana Campos; Eric P Winer; Lauri Welles; Clifford Hudis
Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancer.
Clinical breast cancer 2009;9(2):101-7.
2009: Andrea Bafford; Harold J Burstein; Christina R Barkley; Barbara L Smith; Stuart R Lipsitz; J Dirk Iglehart; Eric P Winer; Mehra Golshan
Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.
Breast cancer research and treatment 2009;115(1):7-12.
2009: Ann H Partridge; Antonio C Wolff; Paul Kelly Marcom; P A Kaufman; L Zhang; Rebecca Gelman; C Moore; D Lake; G F Fleming; Hope S Rugo; J Atkins; E Sampson; D Collyar; Eric P Winer
The impact of sharing results of a randomized breast cancer clinical trial with study participants.
Breast cancer research and treatment 2009;115(1):123-9.
2009: Maura Dickler; Melody A Cobleigh; Kathy D Miller; Pamela M Klein; Eric P Winer
Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer.
Breast cancer research and treatment 2009;115(1):115-21.
2009: Nancy U Lin; Véronique Diéras; Devchand Paul; Dominique Lossignol; Christos Christodoulou; Hans-Joachim Stemmler; Henri Roché; Minetta C Liu; richard greil; Eva Ciruelos; Sibylle Loibl; Stefania Gori; Andrew Wardley; Denise Yardley; Adam Brufsky; Joanne L Blum; Stephen D Rubin; Bernie Dharan; Klaudia Steplewski; Denise Zembryki; Cristina Oliva; Debasish Roychowdhury; Paolo Paoletti; Eric P Winer
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1452-9.
2009: Rachel A Freedman; Yulei He; Eric P Winer; Nancy L Keating
Trends in racial and age disparities in definitive local therapy of early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(5):713-9.
2009: Susana M Campos; Jean Paul Guastalla; Milayna Subar; Paula Abreu; Eric P Winer; David A Cameron
A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases.
Clinical breast cancer 2009;9(1):39-44.
2009: Robert W Carlson; D Craig Allred; Benjamin O Anderson; Harold J Burstein; W Bradford Carter; Stephen B Edge; John K Erban; William B Farrar; Lori J Goldstein; William J Gradishar; Daniel F Hayes; Clifford Hudis; Mohammad Jahanzeb; Krystyna Kiel; Britt-Marie Ljung; Paul Kelly Marcom; Ingrid A Mayer; Beryl Mc Cormick; Lisle M Nabell; Lori J Pierce; Elizabeth C Reed; Mary Lou Smith; George Somlo; Richard L Theriault; Neal S Topham; John H Ward; Eric P Winer; Antonio C Wolff
Breast cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(2):122-92.
2009: Jennifer A Ligibel; Ann Partridge; Anita Giobbie-Hurder; Mehra Golshan; Karen M Emmons; Eric P Winer
Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ.
Annals of surgical oncology 2009;16(1):106-12.
2009: Ian E Krop; Eric P Winer
Ten years of HER2-directed therapy: still questions after all these years.
Breast cancer research and treatment 2009;113(2):207-9.
2008: Rachel A Freedman; Eric P Winer
Reducing disparities in breast cancer care: a daunting but essential responsibility.
Journal of the National Cancer Institute 2008;100(23):1661-3.
2008: Nancy U Lin; Elizabeth Claus; Jessica Sohl; Abdul R Razzak; Amal Arnaout; Eric P Winer
Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases.
Cancer 2008;113(10):2638-45.
2008: Julia S Wong; Alphonse G Taghian; Jennifer Bellon; Aparna Keshaviah; Barbara L Smith; Eric P Winer; Barbara Silver; Jay R Harris
Tangential radiotherapy without axillary surgery in early-stage breast cancer: results of a prospective trial.
International journal of radiation oncology, biology, physics 2008;72(3):866-70.
2008: Sara M Tolaney; Julie Najita; Eric P Winer; Harold J Burstein
Lymphopenia associated with adjuvant anthracycline/ taxane regimens.
Clinical breast cancer 2008;8(4):352-6.
2008: Ann H Partridge; Jeffrey P Winer; Mehra Golshan; Jennifer Bellon; Emily Blood; Elizabeth Dees; Ebonie Sampson; Karen M Emmons; Eric P Winer
Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ.
Clinical breast cancer 2008;8(3):275-80.
2008: Blase N Polite; Constance Cirrincione; Gini F Fleming; Donald A Berry; Andrew D Seidman; Hyman Muss; Larry Norton; Charles Shapiro; Kamal Bakri; Paul Kelly Marcom; Diana Lake; Joel H Schwartz; Clifford Hudis; Eric P Winer
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2659-65.
2008: Rinaa S Punglia; Harold J Burstein; Eric P Winer; Jane C Weeks
Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
Journal of the National Cancer Institute 2008;100(9):642-8.
2008: Minetta C Liu; George D Demetri; Donald A Berry; Larry Norton; Gloria Broadwater; Nicholas J Robert; David Duggan; Daniel F Hayes; I Craig Henderson; Alan Lyss; Judith Hopkins; Peter A Kaufman; Paul Kelly Marcom; Jerry Younger; Nancy U Lin; Katherine Tkaczuk; Eric P Winer; Clifford Hudis
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel.
Cancer treatment reviews 2008;34(3):223-30.
2008: Nancy U Lin; Lisa A Carey; Minetta C Liu; Jerry Younger; Steven E Come; Matthew Ewend; Gordon J Harris; Elizabeth Bullitt; Annick D Van den Abbeele; John W Henson; Xiaochun Li; Rebecca Gelman; Harold J Burstein; Elizabeth Kasparian; David G Kirsch; Ann Crawford; Fred Hochberg; Eric P Winer
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1993-9.
2008: Nancy U Lin; Eric P Winer
Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of time.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1919-21.
2008: Edith A Perez; Vera J Suman; Nancy E Davidson; George W Sledge; Peter A Kaufman; Clifford Hudis; Silvana Martino; Julie R Gralow; Shaker R Dakhil; James N Ingle; Eric P Winer; Karen Gelmon; Bernard J Gersh; Allan S Jaffe; Richard J Rodeheffer
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1231-8.
2008: Michael E Stokes; David Thompson; Eduardo L Montoya; Milton C Weinstein; Eric P Winer; Craig C Earle
Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2008;11(2):213-20.
2008: Jennifer A Ligibel; Nancy Campbell; Ann H Partridge; Wendy Y Chen; Taylor Salinardi; Haiyan Chen; Kristie Adloff; Aparna Keshaviah; Eric P Winer
Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):907-12.
2008: Ann H Partridge; Kristie Adloff; Emily Blood; Elizabeth Dees; Carolyn Kaelin; Mehra Golshan; Jennifer A Ligibel; Janet de Moor; Jane C Weeks; Karen M Emmons; Eric P Winer
Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
Journal of the National Cancer Institute 2008;100(4):243-51.
2008: Julie R Gralow; Harold J Burstein; William Wood; Gabriel N Hortobagyi; Luca Gianni; Gunter von Minckwitz; Aman U Buzdar; Ian E Smith; William F Symmans; Baljit Singh; Eric P Winer
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(5):814-9.
2008: Nancy U Lin; Eric P Winer
Advances in adjuvant endocrine therapy for postmenopausal women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(5):798-805.
2008: Ann H Partridge; Shari Gelber; Jeffrey Peppercorn; Elizabeth Ginsburg; Ebonie Sampson; Randi Rosenberg; Michele Przypyszny; Eric P Winer
Fertility and menopausal outcomes in young breast cancer survivors.
Clinical breast cancer 2008;8(1):65-9.
2008: Ann H Partridge; Andrea LaFountain; Erica L Mayer; Brooke S Taylor; Eric P Winer; Aviva Asnis-Alibozek
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):556-62.
2008: Aman U Buzdar; R Charles Coombes; Paul E Goss; Eric P Winer
Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer.
Cancer 2008;112(3 Suppl):700-9.
2008: Steven E Come; Aman U Buzdar; James N Ingle; Stephen R D Johnston; Angela Brodie; R Charles Coombes; William R Miller; Kathleen I Pritchard; Eric P Winer; Jo Anne Zujewski; Paul E Goss
Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
Cancer 2008;112(3 Suppl):673-8.
2008: Julie R Gralow; Robert F Ozols; Dean F Bajorin; Bruce D Cheson; Howard M Sandler; Eric P Winer; James Bonner; George D Demetri; Walter Curran; Patricia Anne Ganz; Barnett S Kramer; Mark G Kris; Maurie Markman; Robert J Mayer; Derek Raghavan; Scott Ramsey; Gregory H Reaman; Raymond Sawaya; Lynn Schuchter; John W Sweetenham; Linda Vahdat; Nancy E Davidson; Richard L Schilsky; Allen S Lichter
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):313-25.
2008: Robert W Carlson; Susan Moench; Arti Hurria; Lodovico Balducci; Harold J Burstein; Lori J Goldstein; William J Gradishar; Kevin S Hughes; Mohammad Jahanzeb; Stuart M Lichtman; Lawrence Marks; Joan S McClure; Beryl Mc Cormick; Lisle M Nabell; Lori J Pierce; Mary Lou Smith; Neal S Topham; Tiffany A Traina; John H Ward; Eric P Winer
NCCN Task Force Report: breast cancer in the older woman.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6 Suppl 4():S1-25; quiz S26-7.
2008: A Rab Razzak; Nancy U Lin; Eric P Winer
Heterogeneity of breast cancer and implications of adjuvant chemotherapy.
Breast cancer (Tokyo, Japan) 2008;15(1):31-4.
2008: Nancy L Keating; Mary Beth Landrum; Edward Guadagnoli; Eric P Winer; John Z Ayanian
Care in the months before death and hospice enrollment among older women with advanced breast cancer.
Journal of general internal medicine 2008;23(1):11-8.
2007: Elizabeth Bullitt; Nancy U Lin; J Smith; Donglin Zeng; Eric P Winer; Lisa A Carey; Weili Lin; Matthew G Ewend
Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study.
Radiology 2007;245(3):824-30.
2007: Sara M Tolaney; Eric P Winer
Follow-up care of patients with breast cancer.
Breast (Edinburgh, Scotland) 2007;16 Suppl 2():S45-50.
2007: Eric P Winer; Jay R Harris; Barbara L Smith; Helen Anne D'Alessandro; Elena F Brachtel
Case records of the Massachusetts General Hospital. Case 32-2007. A 62-year-old woman with a second breast cancer.
The New England journal of medicine 2007;357(16):1640-8.
2007: Daniel F Hayes; Ann D Thor; Lynn Dressler; Donald Weaver; Susan M Edgerton; David Cowan; Gloria Broadwater; Lori J Goldstein; Silvana Martino; James N Ingle; I Craig Henderson; Larry Norton; Eric P Winer; Clifford Hudis; Matthew J Ellis; Donald A Berry
HER2 and response to paclitaxel in node-positive breast cancer.
The New England journal of medicine 2007;357(15):1496-506.
2007: Sara M Tolaney; Yolanda L Colson; Ritu Gill; Stephanie Schulte; Margaret M Duggan; Larry N Shulman; Eric P Winer
Sarcoidosis mimicking metastatic breast cancer.
Clinical breast cancer 2007;7(10):804-10.
2007: Alice B Kornblith; Mark Powell; Meredith M Regan; Samantha Bennett; Carolyn N Krasner; Beverly Moy; Jerry Younger; Annekathryn Goodman; Ross Berkowitz; Eric P Winer
Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.
Psycho-oncology 2007;16(10):895-903.
2007: David Thompson; Douglas C A Taylor; Eduardo L Montoya; Eric P Winer; Stephen E Jones; Milton C Weinstein
Cost-effectiveness of switching to exemestane after 2 to 3 years of therapy with tamoxifen in postmenopausal women with early-stage breast cancer.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007;10(5):367-76.
2007: Harold J Burstein; Eric P Winer
Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3797-9.
2007: Harold J Burstein; Aparna Keshaviah; Ari D Baron; Ronald D Hart; Rosemary Lambert-Falls; Paul Kelly Marcom; Rebecca Gelman; Eric P Winer
Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
Cancer 2007;110(5):965-72.
2007: Hyman Muss; Donald A Berry; Constance Cirrincione; Daniel R Budman; I Craig Henderson; Marc L Citron; Larry Norton; Eric P Winer; Clifford Hudis
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3699-704.
2007: Nancy U Lin; Leroy M Parker; Steven E Come; Harold J Burstein; Margaret Haldoupis; Nicole Ryabin; Rebecca Gelman; Eric P Winer; Larry N Shulman
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.
Investigational new drugs 2007;25(4):369-75.
2007: Nancy U Lin; Eric P Winer
Optimal use of aromatase inhibitors: to lead or to follow?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2639-41.
2007: Ann H Partridge; Shari Gelber; Richard D Gelber; Monica Castiglione-Gertsch; Aron Goldhirsch; Eric P Winer
Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
European journal of cancer (Oxford, England : 1990) 2007;43(11):1646-53.
2007: Rinaa S Punglia; Monica Morrow; Eric P Winer; Jay R Harris
Local therapy and survival in breast cancer.
The New England journal of medicine 2007;356(23):2399-405.
2007: Patricia Reid Ponte; Anne H Gross; Eric P Winer; Mary J Connaughton; James Hassinger
Implementing an interdisciplinary governance model in a comprehensive cancer center.
Oncology nursing forum 2007;34(3):611-6.
2007: Jeffrey Peppercorn; Emily Blood; Eric P Winer; Ann H Partridge
Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
Cancer 2007;109(7):1239-46.
2007: Harold J Burstein; Beth Overmoyer; Rebecca Gelman; Paula Silverman; Jennifer Savoie; Kathryn Clarke; Leda Dumadag; Jerry Younger; Percy Ivy; Eric P Winer
Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules.
Investigational new drugs 2007;25(2):161-4.
2007: Nancy L Keating; Mary Beth Landrum; Edward Guadagnoli; Eric P Winer; John Z Ayanian
Surveillance testing among survivors of early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(9):1074-81.
2007: Nancy U Lin; Eric P Winer
Brain metastases: the HER2 paradigm.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1648-55.
2007: Robert W Carlson; Benjamin O Anderson; Harold J Burstein; W Bradford Carter; Stephen B Edge; William B Farrar; Lori J Goldstein; William J Gradishar; Daniel F Hayes; Clifford Hudis; Mohammad Jahanzeb; Britt-Marie Ljung; Krystyna Kiel; Lawrence Marks; Beryl Mc Cormick; Lisle M Nabell; Lori J Pierce; Elizabeth C Reed; Samuel Michael Silver; Mary Lou Smith; George Somlo; Richard L Theriault; John H Ward; Eric P Winer; Antonio C Wolff
Invasive breast cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(3):246-312.
2007: Lyndsay N Harris; Fanglei You; Stuart J Schnitt; Agnes Witkiewicz; Xin Lu; Dennis C Sgroi; Paula D Ryan; Steven E Come; Harold J Burstein; Beth-Ann Lesnikoski; Madhavi Kamma; Paula N Friedman; Rebecca Gelman; J Dirk Iglehart; Eric P Winer
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1198-207.
2006: M G Leining; Shari Gelber; R Rosenberg; M Przypyszny; Eric P Winer; Ann H Partridge
Menopausal-type symptoms in young breast cancer survivors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1777-82.
2006: Mercedes Rincon; Gloria Broadwater; Lyndsay Harris; Abigail Crocker; Donald Weaver; Lynn Dressler; Donald Berry; Linda Sutton; Richard Michaelson; Michael Messino; Jeffrey Kirshner; Gini Fleming; Eric P Winer; Clifford Hudis; Stacy Appel; Larry Norton; Hyman Muss
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806.
Breast cancer research and treatment 2006;100(3):301-8.
2006: Sara M Tolaney; Ann H Partridge; Rochelle G Sheib; Harold J Burstein; Eric P Winer
Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5330-1.
2006: Alice B Kornblith; Meredith M Regan; Youngmee Kim; Greta Greer; Beverly Parker; Samantha Bennett; Eric P Winer
Cancer-related communication between female patients and male partners scale: A pilot study.
Psycho-oncology 2006;15(9):780-94.
2006: Robert W Carlson; Susan J Moench; M Elizabeth H Hammond; Edith A Perez; Harold J Burstein; D Craig Allred; Charles L Vogel; Lori J Goldstein; George Somlo; William J Gradishar; Clifford Hudis; Mohammad Jahanzeb; Azadeh Stark; Antonio C Wolff; Michael F Press; Eric P Winer; Soonmyung Paik; Britt-Marie Ljung
HER2 testing in breast cancer: NCCN Task Force report and recommendations.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4 Suppl 3():S1-22; quiz S23-4.
2006: Rinaa S Punglia; Karen M Kuntz; Eric P Winer; Jane C Weeks; Harold J Burstein
The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
Cancer 2006;106(12):2576-82.
2006: Clifford Hudis; Eric P Winer
Cancer and leukemia group B breast committee: decades of progress and plans for the future.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 2):3576s-80s.
2006: Donald A Berry; Constance Cirrincione; I Craig Henderson; Marc L Citron; Daniel R Budman; Lori J Goldstein; Silvana Martino; Edith A Perez; Hyman Muss; Larry Norton; Clifford Hudis; Eric P Winer
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.
JAMA : the journal of the American Medical Association 2006;295(14):1658-67.
2006: Robert W Carlson; Elizabeth Brown; Harold J Burstein; William J Gradishar; Clifford Hudis; Charles L Loprinzi; Eleftherios Paul Mamounas; Edith A Perez; Kathleen Pritchard; Peter M Ravdin; Abram Recht; George Somlo; Richard L Theriault; Eric P Winer; Antonio C Wolff
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4 Suppl 1():S1-26.
2006: Steven E Come; Aman U Buzdar; James N Ingle; Carlos L Arteaga; Myles Brown; Mitch Dowsett; Susan G Hilsenbeck; Rakesh Kumar; Stephen R D Johnston; Adrian V Lee; Soonmyung Paik; Kathleen I Pritchard; Eric P Winer; Carol Hart
Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 2):997s-1000s.
2006: Harold J Burstein; Jennifer Bellon; Sharon Galper; Hsiao-Ming Lu; Irene Kuter; Alphonse G Taghian; Julia S Wong; Rebecca Gelman; Craig A Bunnell; Leroy M Parker; Judy E Garber; Eric P Winer; Jay R Harris; Simon Nicholas Powell
Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
International journal of radiation oncology, biology, physics 2006;64(2):496-504.
2006: Jennifer A Ligibel; Eric P Winer
Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer.
Women's health (London, England) 2006;2(1):89-97.
2006: Elizabeth Bullitt; Nancy U Lin; Matthew G Ewend; Donglin Zeng; Eric P Winer; Lisa A Carey; J Smith
Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancer.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2006;9(Pt 2):561-8.
2006: Lyndsay N Harris; Gloria Broadwater; Nancy U Lin; alexander miron; Stuart J Schnitt; David Cowan; Jonathan Lara; Ira J Bleiweiss; Donald Berry; Matthew Ellis; Daniel F Hayes; Eric P Winer; Lynn Dressler
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342.
Breast cancer research : BCR 2006;8(6):R66.
2006: Nancy L Keating; Mary Beth Landrum; Edward Guadagnoli; Eric P Winer; John Z Ayanian
Factors related to underuse of surveillance mammography among breast cancer survivors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(1):85-94.
2005: Nancy U Lin; Rebecca Gelman; Eric P Winer
Dose density in breast cancer: a simple message?
Journal of the National Cancer Institute 2005;97(23):1712-4.
2005: Jeffrey Peppercorn; Ann H Partridge; Harold J Burstein; Eric P Winer
Standards for follow-up care of patents with breast cancer.
Breast (Edinburgh, Scotland) 2005;14(6):500-8.
2005: Jeffrey A Meyerhardt; Denise Heseltine; HANNIA CAMPOS; Michelle D Holmes; Walter C Willett; Eric P Winer; Peter C Enzinger; Craig A Bunnell; Matthew H Kulke; Charlie S Fuchs
Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8453-60.
2005: Harold J Burstein; Leroy M Parker; Aparna Keshaviah; Jennifer Doherty; Ann H Partridge; Lidia Schapira; Paula D Ryan; Jerry Younger; Lyndsay N Harris; Beverly Moy; Steven E Come; Susan T Schumer; Craig A Bunnell; Margaret Haldoupis; Rebecca Gelman; Eric P Winer
Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8340-7.
2005: Harold J Burstein; Grazyna Lieberman; Dennis J Slamon; Eric P Winer; P Klein
Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1772-7.
2005: Gary H Lyman; Armando E Giuliano; Mark R Somerfield; Al B Benson; Diane C Bodurka; Harold J Burstein; Alistair J Cochran; Hiram S Cody; Stephen B Edge; Sharon Galper; James A Hayman; Theodore Y Kim; Cheryl L Perkins; Donald A Podoloff; Visa Haran Sivasubramaniam; Roderick R Turner; Richard L Wahl; Donald L Weaver; Antonio C Wolff; Eric P Winer
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7703-20.
2005: Jeffrey Peppercorn; James Herndon; Alice B Kornblith; William Peters; Tim A Ahles; James J Vredenburgh; Gary Schwartz; Elizabeth J Shpall; David D Hurd; Jimmie C Holland; Eric P Winer
Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
Cancer 2005;104(8):1580-9.
2005: Ian Krop; Eric P Winer
Ovarian suppression for breast cancer: an effective treatment in search of a home.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):5869-72.
2005: Rinaa S Punglia; Karen M Kuntz; Eric P Winer; Jane C Weeks; Harold J Burstein
Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5178-87.
2005: Ann H Partridge; Eric P Winer
Fertility after breast cancer: questions abound.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(19):4259-61.
2005: Harold J Burstein; Eric P Winer
HER2 or not HER2: that is the question.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3656-9.
2005: Robert W Carlson; Benjamin O Anderson; Harold J Burstein; Charles E Cox; Stephen B Edge; William B Farrar; Lori J Goldstein; William J Gradishar; Daniel F Hayes; Clifford Hudis; Mohammad Jahanzeb; Britt-Marie Ljung; Lawrence Marks; Beryl Mc Cormick; Lisle M Nabell; Lori J Pierce; Elizabeth C Reed; Samuel Michael Silver; Mary Lou Smith; George Somlo; Richard L Theriault; John H Ward; Eric P Winer; Antonio C Wolff
Breast cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(3):238-89.
2005: Ann H Partridge; Julia S Wong; Katherine Knudsen; Rebecca Gelman; Ebonie Sampson; Michele A Gadd; Karyn L Bishop; Jay R Harris; Eric P Winer
Offering participants results of a clinical trial: sharing results of a negative study.
Lancet 2005;365(9463):963-4.
2005: Eric P Winer
Optimizing endocrine therapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(8):1609-10.
2005: Hyman Muss; Susan Woolf; Donald Berry; Constance Cirrincione; Raymond B Weiss; Daniel R Budman; William C Wood; I Craig Henderson; Clifford Hudis; Eric P Winer; Harvey Cohen; Judith Wheeler; Larry Norton
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.
JAMA : the journal of the American Medical Association 2005;293(9):1073-81.
2005: Sharon Galper; Emily Blood; Rebecca Gelman; Anthony Abner; Abram Recht; Anita Kohli; Julia S Wong; Darrell Smith; Jennifer Bellon; James Connolly; Stuart J Schnitt; Eric P Winer; Barbara Silver; Jay R Harris
Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.
International journal of radiation oncology, biology, physics 2005;61(2):348-57.
2005: Eve Wittenberg; Eric P Winer; Jane C Weeks
Patient utilities for advanced cancer: effect of current health on values.
Medical care 2005;43(2):173-81.
2005: Eric P Winer; Clifford Hudis; Harold J Burstein; Antonio C Wolff; Kathleen I Pritchard; James N Ingle; Rowan T Chlebowski; Richard D Gelber; Stephen B Edge; Julie R Gralow; Melody A Cobleigh; Eleftherios P Mamounas; Lori J Goldstein; Timothy J Whelan; Trevor J Powles; John Bryant; Cheryl Perkins; Judy Perotti; Susan Braun; Amy S Langer; George P Browman; Mark R Somerfield
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):619-29.
2005: Jennifer A Ligibel; Eric P Winer
Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions.
Breast cancer research : BCR 2005;7(6):255-7.
2005: Nancy L Keating; Mary Beth Landrum; John Z Ayanian; Eric P Winer; Edward Guadagnoli
The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries.
Journal of general internal medicine 2005;20(1):38-44.
2004: Nicholas J Robert; Charles L Vogel; I Craig Henderson; Joseph A Sparano; Melvin R Moore; Paula Silverman; Beth Overmoyer; Charles L Shapiro; John W Park; Gail T Colbern; Eric P Winer; Alberto Gabizon
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer.
Seminars in oncology 2004;31(6 Suppl 13):106-46.
2004: David S Alberts; Franco M Muggia; James Carmichael; Eric P Winer; Mohammad Jahanzeb; Alan P Venook; Keith M Skubitz; Edgardo Rivera; Joseph A Sparano; Nicholas J DiBella; Simon J Stewart; John J Kavanagh; Alberto Gabizon
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials.
Seminars in oncology 2004;31(6 Suppl 13):53-90.
2004: Ann H Partridge; Shari Gelber; Jeffrey Peppercorn; Ebonie Sampson; Katherine Knudsen; Marc Laufer; Randi Rosenberg; Michele Przypyszny; Alison Rein; Eric P Winer
Web-based survey of fertility issues in young women with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4174-83.
2004: Kevin S Hughes; Lauren A Schnaper; Donald Berry; Constance Cirrincione; Beryl Mc Cormick; Brenda Shank; Judith Wheeler; Lorraine A Champion; Thomas J Smith; Barbara L Smith; Charles Shapiro; Hyman Muss; Eric P Winer; Clifford Hudis; William Wood; David Sugarbaker; I Craig Henderson; Larry Norton
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer.
The New England journal of medicine 2004;351(10):971-7.
2004: Nancy U Lin; Jennifer Bellon; Eric P Winer
CNS metastases in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(17):3608-17.
2004: Eric P Winer; Donald A Berry; Susan Woolf; David B Duggan; Alice B Kornblith; Lyndsay N Harris; Richard A Michaelson; Jeffrey A Kirshner; Gini F Fleming; Michael C Perry; Mark Graham II; Stewart A Sharp; Roger Keresztes; I Craig Henderson; Clifford Hudis; Hyman Muss; Larry Norton
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2061-8.
2004: Ann H Partridge; Nadia Hackett; Emily Blood; Rebecca Gelman; Steven Joffe; Susan Bauer-Wu; Katherine Knudsen; Karen M Emmons; Deborah Collyar; Richard L Schilsky; Eric P Winer
Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants.
Journal of the National Cancer Institute 2004;96(8):629-32.
2004: Elena B Elkin; Milton C Weinstein; Eric P Winer; Karen M Kuntz; Stuart J Schnitt; Jane C Weeks
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(5):854-63.
2004: Ann H Partridge; Eric P Winer
Long-term complications of adjuvant chemotherapy for early stage breast cancer.
Breast disease 2004;21():55-64.
2004: Nancy U Lin; Eric P Winer
New targets for therapy in breast cancer: small molecule tyrosine kinase inhibitors.
Breast cancer research : BCR 2004;6(5):204-10.
2003: Nancy L Keating; Mary Beth Landrum; John Z Ayanian; Eric P Winer; Edward Guadagnoli
Consultation with a medical oncologist before surgery and type of surgery among elderly women with early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4532-9.
2003: Ann H Partridge; Eric P Winer; Harold J Burstein
Follow-up care of breast cancer survivors.
Seminars in oncology 2003;30(6):817-25.
2003: Lynn Schuchter; Neal J Meropol; Eric P Winer; Martee Hensley; Mark R Somerfield
Amifostine and chemoradiation therapy: ASCO responds.
The lancet oncology 2003;4(10):593.
2003: Harold J Burstein; Lyndsay N Harris; Paul Kelly Marcom; Rosemary Lambert-Falls; Kathleen Havlin; Beth Overmoyer; Robert J Friedlander; Janet Gargiulo; Rochelle Strenger; Charles L Vogel; Paula D Ryan; Matthew J Ellis; Raquel A Nunes; Craig A Bunnell; Susana Campos; Michele Hallor; Rebecca Gelman; Eric P Winer
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2889-95.
2003: Leslie G Bluman; Barbara K Rimer; Katherine Regan Sterba; Julia Lancaster; Shelly Clark; Nancy Borstelmann; J Dirk Iglehart; Eric P Winer
Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
Psycho-oncology 2003;12(5):410-27.
2003: Eric P Winer; Clifford Hudis; Harold J Burstein; John Bryant; Rowan T Chlebowski; James N Ingle; Stephen B Edge; Eleftherios P Mamounas; Richard Gelber; Julie R Gralow; Lori J Goldstein; Kathleen I Pritchard; Susan Braun; Melody A Cobleigh; Amy S Langer; Judy Perotti; Trevor J Powles; Timothy J Whelan; George P Browman
American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(13):2597-9.
2003: Johanna C Bendell; Susan M Domchek; Harold J Burstein; Lyndsay Harris; Jerry Younger; Irene Kuter; Craig A Bunnell; Montse Rue; Rebecca Gelman; Eric P Winer
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
Cancer 2003;97(12):2972-7.
2003: Harold J Burstein; George D Demetri; Elisabetta Mueller; pasha sarraf; Bruce M Spiegelman; Eric P Winer
Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study.
Breast cancer research and treatment 2003;79(3):391-7.
2003: Craig C Earle; Harold J Burstein; Eric P Winer; Jane C Weeks
Quality of non-breast cancer health maintenance among elderly breast cancer survivors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1447-51.
2003: Marc L Citron; Donald A Berry; Constance Cirrincione; Clifford Hudis; Eric P Winer; William J Gradishar; Nancy E Davidson; Silvana Martino; Robert Livingston; James N Ingle; Edith A Perez; John Carpenter; David D Hurd; James F Holland; Barbara L Smith; Carolyn I Sartor; Eleanor H Leung; Jeffrey Abrams; Richard L Schilsky; Hyman Muss; Larry Norton
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1431-9.
2003: Jennifer A Ligibel; Eric P Winer
The aromatase inhibitors as adjuvant therapy for hormone receptor-positive breast cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2003;1(2):215-21.
2003: Ann H Partridge; Harold J Burstein; Rebecca Gelman; Paul Kelly Marcom; Eric P Winer
Do patients participating in clinical trials want to know study results?
Journal of the National Cancer Institute 2003;95(6):491-2.
2003: Aman U Buzdar; Joyce A O'Shaughnessy; Daniel J Booser; John Pippen; Stephen E Jones; Pamela N Munster; Patrick Peterson; Allen S Melemed; Eric P Winer; Clifford Hudis
Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1007-14.
2003: Ann H Partridge; Philip S Wang; Eric P Winer; Jerry Avorn
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(4):602-6.
2003: Susana Campos; Eric P Winer
Hormonal therapy in postmenopausal women with breast cancer.
Oncology 2003;64(4):289-99.
2003: Jennifer A Ligibel; Eric P Winer
Clinical differences among the aromatase inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):473S-9S.
2003: Steven E Come; Aman U Buzdar; Carlos L Arteaga; Angela Brodie; Nancy E Davidson; Mitch Dowsett; James N Ingle; Stephen R D Johnston; Adrian V Lee; C Kent Osborne; Kathleen I Pritchard; Victor G Vogel; Eric P Winer; Carol S Hart
Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):443S-6S.
2003: Harold J Burstein; Lyndsay N Harris; Rebecca Gelman; Susan C Lester; Raquel A Nunes; Carolyn M Kaelin; Leroy M Parker; Leif W Ellisen; Irene Kuter; Michele A Gadd; Roger L Christian; Patricia Rae Kennedy; Virginia F Borges; Craig A Bunnell; Jerry Younger; Barbara L Smith; Eric P Winer
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(1):46-53.
2002: Lisa M DiGianni; Judy E Garber; Eric P Winer
Complementary and alternative medicine use among women with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(18 Suppl):34S-8S.
2002: Craig A Bunnell; Eric P Winer
Lumping versus splitting: the splitters take this round.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(17):3576-7.
2002: Rowan T Chlebowski; Nananda F Col; Eric P Winer; Deborah E Collyar; Steven R Cummings; Victor G Vogel; Harold J Burstein; Andrea Eisen; Isaac M Lipkus; David G Pfister
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3328-43.
2002: Eric P Winer; Clifford Hudis; Harold J Burstein; Rowan T Chlebowski; James N Ingle; Stephen B Edge; Eleftherios P Mamounas; Julie R Gralow; Lori J Goldstein; Kathleen I Pritchard; Susan Braun; Melody A Cobleigh; Amy S Langer; Judy Perotti; Trevor J Powles; Timothy J Whelan; George P Browman
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3317-27.
2002: Ann H Partridge; Eric P Winer
Informing clinical trial participants about study results.
JAMA : the journal of the American Medical Association 2002;288(3):363-5.
2002: Lynn Schuchter; Martee Hensley; Neal J Meropol; Eric P Winer
2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(12):2895-903.
2002: Jennifer A Ligibel; Eric P Winer
Trastuzumab/chemotherapy combinations in metastatic breast cancer.
Seminars in oncology 2002;29(3 Suppl 11):38-43.
2002: Ann H Partridge; Jerry Avorn; Philip S Wang; Eric P Winer
Adherence to therapy with oral antineoplastic agents.
Journal of the National Cancer Institute 2002;94(9):652-61.
2002: Celette Sugg Skinner; Joellen M Schildkraut; Donald Berry; Brian Calingaert; Paul Kelly Marcom; Jeremy Sugarman; Eric P Winer; J Dirk Iglehart; P Andrew Futreal; Barbara K Rimer
Pre-counseling education materials for BRCA testing: does tailoring make a difference?
Genetic testing 2002;6(2):93-105.
2002: Lyndsay Harris; Gerald Batist; Robert Belt; Douglas Rovira; Rudolph Navari; Nozar Azarnia; Lauri Welles; Eric P Winer
Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma.
Cancer 2002;94(1):25-36.
2001: Joseph A Sparano; Eric P Winer
Liposomal anthracyclines for breast cancer.
Seminars in oncology 2001;28(4 Suppl 12):32-40.
2001: Harold J Burstein; Craig A Bunnell; Eric P Winer
New cytotoxic agents and schedules for advanced breast cancer.
Seminars in oncology 2001;28(4):344-58.
2001: Leslie G Bluman; Nancy Borstelmann; Barbara K Rimer; J Dirk Iglehart; Eric P Winer
Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ.
Journal of women's health & gender-based medicine 2001;10(6):589-98.
2001: Harold J Burstein; Irene Kuter; Susana Campos; Rebecca Gelman; L Tribou; Leroy M Parker; Judith Manola; Jerry Younger; Ursula Matulonis; Craig A Bunnell; Ann H Partridge; Paul G Richardson; K Clarke; Larry N Shulman; Eric P Winer
Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2722-30.
2001: Wendy Demark-Wahnefried; Bercedis L Peterson; Eric P Winer; Lawrence Marks; N Aziz; Paul Kelly Marcom; Kimberly Blackwell; Barbara K Rimer
Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(9):2381-9.
2001: Ann H Partridge; Craig A Bunnell; Eric P Winer
Quality of life issues among women undergoing high-dose chemotherapy for breast cancer.
Breast disease 2001;14():41-50.
2001: Ann H Partridge; Harold J Burstein; Eric P Winer
Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer.
Journal of the National Cancer Institute. Monographs 2001;(30):135-42.
2001: Eric P Winer; Harold J Burstein
New combinations with Herceptin in metastatic breast cancer.
Oncology 2001;61 Suppl 2():50-7.
2000: R W Carlson; Benjamin O Anderson; W Bensinger; C E Cox; Nancy E Davidson; S B Edge; W B Farrar; Lori J Goldstein; William J Gradishar; Allen S Lichter; Beryl Mc Cormick; Lisle M Nabell; Elizabeth C Reed; Samuel Michael Silver; M L Smith; G Somlo; Richard Theriault; John H Ward; Eric P Winer; Antonio C Wolff
NCCN Practice Guidelines for Breast Cancer.
Oncology (Williston Park, N.Y.) 2000;14(11A):33-49.
2000: Harold J Burstein; Eric P Winer
Primary care for survivors of breast cancer.
The New England journal of medicine 2000;343(15):1086-94.
2000: Ann H Partridge; Eric P Winer
Use of taxanes in the treatment of patients with breast cancer has increased dramatically over the past 8 years.
Clinical breast cancer 2000;1(2):164-5.
2000: Said Baidas; Eric P Winer; G F Fleming; L Harris; J M Pluda; J G Crawford; H Yamauchi; Claudine Isaacs; John Hanfelt; Mariella Tefft; David A Flockhart; M D Johnson; Michael J Hawkins; Marc Lippman; Daniel F Hayes
Phase II evaluation of thalidomide in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2710-7.
2000: alexander miron; Joellen M Schildkraut; Barbara K Rimer; Eric P Winer; Celette Sugg Skinner; P Andrew Futreal; D Culler; Brian Calingaert; S Clark; P Kelly Marcom; J Dirk Iglehart
Testing for hereditary breast and ovarian cancer in the southeastern United States.
Annals of surgery 2000;231(5):624-34.
2000: J Speice; J Harkness; H Laneri; R Frankel; Debra Roter; Alice B Kornblith; Tim A Ahles; Eric P Winer; Stewart Fleishman; P Luber; Michael Zevon; R McQuellon; P Trief; J Finkel; J Spira; D Greenberg; J Rowland; Jimmie C Holland
Involving family members in cancer care: focus group considerations of patients and oncological providers.
Psycho-oncology 2000;9(2):101-12.
2000: Harold J Burstein; Judith Manola; Jerry Younger; Leroy M Parker; Craig A Bunnell; Rochelle G Scheib; Ursula Matulonis; Judy E Garber; K D Clarke; Larry N Shulman; Eric P Winer
Docetaxel administered on a weekly basis for metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1212-9.
2000: Nancy A Dawson; M Conaway; Susan Halabi; Eric P Winer; Eric J Small; D Lake; Nicholas J Vogelzang
A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181.
Cancer 2000;88(4):825-34.
1999: Martee Hensley; Lynn Schuchter; Celeste Lindley; N J Meropol; GARY COHEN; G Broder; W J Gradishar; D M Green; R J Langdon; R B Mitchell; R Negrin; Ted P Szatrowski; J T Thigpen; Daniel Von Hoff; T H Wasserman; Eric P Winer; David G Pfister
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3333-55.
1999: Harold J Burstein; MJ Ramirez; William P Petros; K D Clarke; MA Warmuth; Paul Kelly Marcom; Ursula Matulonis; Leroy M Parker; Lyndsay N Harris; Eric P Winer
Phase I study of Doxil and vinorelbine in metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(9):1113-6.
1999: Philip W Kantoff; Susan Halabi; M Conaway; Joel Picus; J Kirshner; Vera Hars; D Trump; Eric P Winer; Nicholas J Vogelzang
Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2506-13.
1999: Giovanni Parmigiani; D A Berry; Eric P Winer; C Tebaldi; J Dirk Iglehart; Leonard R Prosnitz
Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1465-73.
1999: M E Costanza; Raymond B Weiss; I Craig Henderson; Larry Norton; Donald A Berry; Constance Cirrincione; Eric P Winer; William C Wood; E Frei; O R McIntyre; Richard L Schilsky
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1397-406.
1999: Eric P Winer; Celeste Lindley; Matthew E Hardee; W T Sawyer; C Brunatti; Nancy Borstelmann; W Peters
Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support.
Psycho-oncology 1999;8(2):167-76.
1999: Leslie G Bluman; Barbara K Rimer; D A Berry; Nancy Borstelmann; J Dirk Iglehart; K Regan; Joellen M Schildkraut; Eric P Winer
Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):1040-6.
1999: P E Goss; Eric P Winer; I F Tannock; Lawrence H Schwartz
Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):52-63.
1999: Kathleen Havlin; MJ Ramirez; C M Legler; Lyndsay N Harris; Ursula Matulonis; J A Hohneker; Daniel F Hayes; Eric P Winer
Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer.
Cancer chemotherapy and pharmacology 1999;43(1):68-72.
1998: Tammy O Tengs; Eric P Winer; S Paddock; O Aguilar-Chavez; D A Berry
Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis.
Medical decision making : an international journal of the Society for Medical Decision Making 1998;18(4):365-75.
1998: Craig A Bunnell; Eric P Winer
Oral 5-FU analogues in the treatment of breast cancer.
Oncology (Williston Park, N.Y.) 1998;12(10 Suppl 7):39-43.
1998: MA Warmuth; G Bowen; Leonard R Prosnitz; L Chu; Gloria Broadwater; Bercedis Peterson; George S Leight; Eric P Winer
Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey.
Cancer 1998;83(7):1362-8.
1998: J Dirk Iglehart; alexander miron; Barbara K Rimer; Eric P Winer; Donald Berry; M J Shildkraut
Overestimation of hereditary breast cancer risk.
Annals of surgery 1998;228(3):375-84.
1998: Thomas S Frank; S A Manley; O I Olopade; S Cummings; Judy E Garber; B Bernhardt; K Antman; D Russo; M E Wood; L Mullineau; C Isaacs; Beth N Peshkin; S Buys; Vickie Venne; Peter T Rowley; Starlene Loader; Kenneth Offit; Mark Robson; H Hampel; D Brener; Eric P Winer; S Clark; B Weber; L C Strong; A Thomas
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2417-25.
1998: Tracy Thomason; Jeannine S McCune; Stephen A Bernard; Eric P Winer; S Tremont; Celeste Lindley
Cancer pain survey: patient-centered issues in control.
Journal of pain and symptom management 1998;15(5):275-84.
1998: Barbara K Rimer; Jeremy Sugarman; Eric P Winer; Leslie G Bluman; C Lerman
Informed consent for BRCA1 and BRCA2 testing.
Breast disease 1998;10(1-2):99-114.
1998: Celeste Lindley; S Vasa; W T Sawyer; Eric P Winer
Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1380-7.
1997: I Tessaro; Nancy Borstelmann; K Regan; Barbara K Rimer; Eric P Winer
Genetic testing for susceptibility to breast cancer: findings from women's focus groups.
Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research 1997;6(3):317-27.
1997: Wendy Demark-Wahnefried; Barbara K Rimer; Eric P Winer
Weight gain in women diagnosed with breast cancer.
Journal of the American Dietetic Association 1997;97(5):519-26, 529; quiz 527-8.
1997: Wendy Demark-Wahnefried; V Hars; M R Conaway; Kathleen Havlin; Barbara K Rimer; G McElveen; Eric P Winer
Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy.
The American journal of clinical nutrition 1997;65(5):1495-501.
1997: MA Warmuth; Linda M Sutton; Eric P Winer
A review of hereditary breast cancer: from screening to risk factor modification.
The American journal of medicine 1997;102(4):407-15.
1997: D A Berry; Giovanni Parmigiani; J Sanchez; Joellen M Schildkraut; Eric P Winer
Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
Journal of the National Cancer Institute 1997;89(3):227-38.
1997: Linda M Sutton; MA Warmuth; William P Petros; Eric P Winer
Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial.
Cancer chemotherapy and pharmacology 1997;40(4):335-41.
1996: K Fee-Fulkerson; M R Conaway; Eric P Winer; C C Fulkerson; Barbara K Rimer; Gregory S Georgiade
Factors contributing to patient satisfaction with breast reconstruction using silicone gel implants.
Plastic and reconstructive surgery 1996;97(7):1420-6.
1996: L Chu; Linda M Sutton; Bercedis L Peterson; K A Havlin; Eric P Winer
Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.
The Journal of infusional chemotherapy 1996;6(4):211-6.
1995: Eric P Winer; L Chu; D V Spicer
Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer.
Seminars in oncology 1995;22(2 Suppl 5):72-8; discussion 78-9.
1994: Eric K Rowinsky; D A Noe; D L Trump; Eric P Winer; V S Lucas; W A Wargin; JA Hohneker; B Lubejko; SE Sartorius; David S Ettinger
Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(9):1754-63.
1994: Eric P Winer
Quality-of-life research in patients with breast cancer.
Cancer 1994;74(1 Suppl):410-5.
1994: Eric P Winer; Linda M Sutton
Quality of life after bone marrow transplantation.
Oncology (Williston Park, N.Y.) 1994;8(1):19-27; discussion 27-8, 31.
1993: Eric P Winer; K Fee-Fulkerson; C C Fulkerson; Gregory S Georgiade; K E Catoe; M Conaway; C Brunatti; V Holmes; Barbara K Rimer
Silicone controversy: a survey of women with breast cancer and silicone implants.
Journal of the National Cancer Institute 1993;85(17):1407-11.
1993: Wendy Demark-Wahnefried; Eric P Winer; Barbara K Rimer
Why women gain weight with adjuvant chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1418-29.
1992: D L Trump; David C Smith; P G Ellis; M P Rogers; S Clifford Schold; Eric P Winer; T J Panella; V C Jordan; R L Fine
High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine.
Journal of the National Cancer Institute 1992;84(23):1811-6.
1992: T J Panella; David C Smith; S Clifford Schold; M P Rogers; Eric P Winer; R L Fine; Jeffrey Crawford; J E Herndon; D L Trump
Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.
Cancer research 1992;52(9):2456-9.
1990: David M. Brizel; Eric P Winer; Leonard R Prosnitz; J Scott; Jeffrey Crawford; Joseph O Moore; Jon P Gockerman
Improved survival in advanced Hodgkin's disease with the use of combined modality therapy.
International journal of radiation oncology, biology, physics 1990;19(3):535-42.
1985: A Rosenberg; Eric P Winer; E Cadman
The use of adjuvant chemotherapy for breast cancer in a community practice.
Connecticut medicine 1985;49(5):281-5.